Peter Siesjö
Clinical trials sponsored by Peter Siesjö, explained in plain language.
-
Egg powder breakthrough? new trial targets brain cancer survival
Disease control Recruiting nowThis study tests if a daily egg powder enriched with a natural protein (antisecretory factor) can help people with newly diagnosed glioblastoma live longer. About 300 adults aged 18-75 who have had surgery and are scheduled for chemo or radiation will take the powder or a placebo…
Phase: PHASE2, PHASE3 • Sponsor: Peter Siesjö • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Egg powder breakthrough: could salovum ease brain injury?
Disease control Recruiting nowThis study tests whether a special egg yolk powder called Salovum can help people with severe traumatic brain injury. About 20 participants will receive either Salovum or a placebo powder alongside standard care. Researchers will measure brain pressure, oxygen levels, and inflamm…
Phase: PHASE2 • Sponsor: Peter Siesjö • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Egg yolk powder takes on brain tumors: new trial tests pressure relief
Knowledge-focused Recruiting nowThis early-phase trial is testing whether a special egg yolk powder called Salovum® can reduce pressure inside glioblastoma brain tumors. Ten adults with suspected glioblastoma will have pressure and oxygen probes placed during a biopsy, then take Salovum® for a few days. The goa…
Phase: PHASE2 • Sponsor: Peter Siesjö • Aim: Knowledge-focused
Last updated May 26, 2026 09:27 UTC